Hop Extract Anti-Inflammatory Effect on Human Chondrocytes Is Potentiated When Encapsulated in Rapeseed Lecithin Nanoliposomes
Open Access
- 17 October 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (20) , 12423
Abstract
Hop (Humulus lupulus L.) is a plant used as an ingredient in beer or employed for its anti-inflammatory properties. The cultivation of hops is currently dedicated to the brewing industry, where mainly female flowers are used, whereas aerial parts, such as leaves, are considered coproducts. Osteoarthritis is the most common musculoskeletal disease associated with low-grade cartilage inflammation. Liposomes have been shown to be promising systems for drug delivery to cartilage cells, called chondrocytes. The aim of our work was to vectorize hop extract valorized from coproducts as a therapeutic agent to alleviate inflammation in human chondrocytes in vitro. Liquid chromatography allowed the identification of oxidized bitter acids in a methanolic extract obtained from the leaves of Cascade hops. The extract was encapsulated in rapeseed lecithin nanoliposomes, and the physicochemical properties of empty or loaded nanoliposomes exhibited no difference. Increasing concentrations of the hop extract alone, empty nanoliposomes, and loaded nanoliposomes were tested on human chondrocytes to assess biocompatibility. The appropriate conditions were applied to chondrocytes stimulated with interleukin-1β to evaluate their effect on inflammation. The results reveal that encapsulation potentiates the hop extract anti-inflammatory effect and that it might be able to improve joint inflammation in osteoarthritis. Furthermore, these results also show that a “zero waste” chain is something that can be achieved in hop cultivation.Keywords
Funding Information
- “Pôle Ingénierie Thérapeutique et Moléculaire—Santé” de la Région Lorraine (CNRS/Université de Lorraine)
- “PEPS—Projets Exploratoires Premier Soutien” Mirabelle (CNRS/Université de Lorraine)
- “3BR—Biomolécules et Biomatériaux pour la Bioéconomie Régionale” Project (Région Grand Est, France)
This publication has 77 references indexed in Scilit:
- Identification and Quantification of the Oxidation Products Derived from α-Acids and β-Acids During Storage of Hops (Humulus lupulus L.)Journal of Agricultural and Food Chemistry, 2013
- Osteoarthritis: A disease of the joint as an organArthritis & Rheumatism, 2012
- Inhibitors of hyaluronan export from hops prevent osteoarthritic reactionsMolecular Nutrition & Food Research, 2010
- Xanthohumol from Hop (Humulus lupulus L.) Is an Efficient Inhibitor of Monocyte Chemoattractant Protein-1 and Tumor Necrosis Factor-α Release in LPS-Stimulated RAW 264.7 Mouse Macrophages and U937 Human MonocytesJournal of Agricultural and Food Chemistry, 2009
- Hop (Humulus lupulus)-Derived Bitter Acids as Multipotent Bioactive CompoundsJournal of Natural Products, 2009
- Update on the biology of the chondrocyte and new approaches to treating cartilage diseasesBest Practice & Research Clinical Rheumatology, 2006
- Selective Inhibition of COX-2 by a Standardized CO2Extract ofHumulus lupulus in vitroand its Activity in a Mouse Model of Zymosan-Induced ArthritisPlanta Medica, 2006
- Potent Inhibition of the Master Chondrogenic FactorSox9 Gene by Interleukin-1 and Tumor Necrosis Factor-αJournal of Biological Chemistry, 2000
- Mono‐iodoacetate‐induced experimental osteoarthritis. A dose‐response study of loss of mobility, morphology, and biochemistryArthritis & Rheumatism, 1997
- In vivo effects of interleukin‐1 on articular cartilage. Prolongation of proteoglycan metabolic disturbances in old miceArthritis & Rheumatism, 1991